Dr. Chaelin "Karen" Ra received her PhD in Preventive Medicine at the University of Southern California and MPH at Seoul National University. She completed her postdoctoral fellowship at the TSET Health Promotion Research Center of Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, focusing on tobacco cessation using mHealth technologies.
Chaelin “Karen” Ra, PhD, MPH
Assistant Professor
The Rutgers Cancer Institute Clinical Research Program is organized based on disease teams, mainly related to specific diagnoses. Some of the Disease Specific Groups are more thematic: Early Drug Development (Phase 1), Precision Medicine, and Cellular Therapies. Each disease team reviews available clinical trials or develops their own trials to meet the clinical needs of patients within their area of expertise (for example, breast cancer) at Rutgers Cancer Institute and RWJBarnabas Health sites for all patients across the system.
